NCT02813135 2026-01-16
ESMART
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
Clinical Trials
4 trialsNCT05372536 2024-11-29
INTACTatHome
Rigshospitalet, Denmark
Phase NA Completed
NCT05601830 2024-11-06
Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China
Phase 1 Terminated
NCT02067143 2021-09-08
LAL1913
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2 Completed